We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

No more tears

16 December 2004 By Robert Cyran

The price suggests that the US healthcare giant is destroying a slight amount of capital in exchange for growth. One wild card: combining the two groups technologies could yield synergies. But any resulting products aren’t likely until 2008.

This content is for Subscribers only

 

Email a friend

Please complete the form below.

Required fields *

*
*
*

(Separate multiple email addresses with commas)